Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Gabapentin for PONV in Sleeve Gastrectomy
NCT05620641Phase 3Completed
- Sponsor
- Tanta University
- Start
- Oct 2022
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in postoperative nausea and vomiting (PONV), sponsored by Tanta University. Started Oct 2022; status: completed.
02
Drugs
gabapentin
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05620641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05620641.